Family Medicine · Seattle, WA
NPI
1750965653
Since 2021
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2511 SW Trenton St
Seattle, WA, 98106
Phone (206) 763-5057
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$110K
778 prescriptions
Company payments, 2025
$694
From 7 companies
Medicare prescription drug claims, 2024
In 2024, the drug Sameer Valluri prescribed most often to Medicare patients was Atorvastatin Calcium, with 60 prescriptions and refills. In total Sameer Valluri wrote 778 Medicare prescriptions that cost $110K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 60 | 178 | 23 | $820 |
| Metformin Hcl Generic | 44 | 94 | 11 | $313 |
| Amlodipine Besylate Generic | 33 | 89 | 15 | $102 |
| Losartan Potassium Generic | 31 | 79 | 14 | $311 |
| Potassium Chloride-0.9% Nacl Potassium Chloride In 0.9%nacl | 23 | 23 | Under 11 | $654 |
| Gabapentin Generic | 21 | 53 | 11 | $653 |
| Carvedilol Generic | 19 | 34 | Under 11 | $265 |
| Lisinopril Generic | 17 | 45 | Under 11 | $89.24 |
| Trazodone Hcl Generic | 16 | 46 | Under 11 | $292 |
| Ondansetron Odt Ondansetron | 15 | 15 | Under 11 | $213 |
| Levothyroxine Sodium Generic | 14 | 28 | Under 11 | $90.77 |
| Omeprazole Generic | 13 | 34 | Under 11 | $222 |
| Fluticasone Propionate Generic | 13 | 28 | Under 11 | $250 |
| Rosuvastatin Calcium Generic | 12 | 32 | Under 11 | $363 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 12 | 32 | Under 11 | $173 |
Brand drugs: - claims; generic drugs: 678 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sameer Valluri $694 ($694 in general payments such as food, travel and fees) from 7 companies. The largest payer was Gilead Sciences, Inc. with $256.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.